FAQ: BioAdaptives' MyndMed™ Receives WADA-Compliant Certification from TruShield™
Summary
What is the main topic of this announcement?
BioAdaptives, Inc. (OTCMKTS: BDPT) has received WADA-compliant certification from TruShield™ Laboratory Services for its nootropic formula MyndMed™, confirming it contains no banned substances and meets safety standards for competitive athletes.
Why is this certification significant for athletes?
The certification allows MyndMed™ to be integrated into the UFC’s approved supplement pool, providing fighters with cognitive performance, focus, and reaction-time support without risking anti-doping violations during competition.
Who conducted the testing and certification?
TruShield™ Laboratory Services conducted the testing, using protocols trusted by professional sports organizations including the UFC®, to verify WADA compliance and the absence of banned substances.
What specific benefits does MyndMed™ provide?
MyndMed™ is a nootropic formula designed to support cognitive performance, focus, and reaction-time enhancement for athletes and other users seeking mental performance benefits.
How does this certification impact BioAdaptives as a company?
This certification supports BioAdaptives’ mission to develop science-based natural health products and enhances their credibility in the sports nutrition market, particularly with professional athletic organizations.
Where can I find more information about BioAdaptives and their products?
For more information about BioAdaptives and their products, visit their website at www.bioadaptives.com or view the full press release at https://ibn.fm/7UohQ.
What types of products does BioAdaptives develop?
BioAdaptives develops and markets science-based natural health and wellness products for both humans and animals, leveraging research in stem cell biology, adaptogens, and regenerative nutrition.
Which professional sports organizations trust TruShield’s protocols?
TruShield’s protocols are trusted by professional sports organizations including the UFC®, as mentioned in the certification announcement for MyndMed™.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 170442